NCT00775398View on ClinicalTrials.gov

Observational Study Assessing the Impact of Exposure to THROMBIN-JMI® on Coagulation Parameters.

CompletedOBSERVATIONAL
Enrollment

553

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

November 30, 2009

Conditions
Blood Coagulation
Trial Locations (43)

Unknown

Birmingham

Mobile

Tucson

Little Rock

Arcadia

Glendale

Pasadena

San Diego

Boca Raton

Melbourne

Miami

Orlando

Chicago

Springfield

Fort Wayne

Indianapolis

Muncie

Lexington

Shreveport

Salisbury

Springfield

Detroit

Flint

Grand Blanc

Royal Oak

Saginaw

Jackson

Kansas City

Billings

Hackensack

Manhasset

New York

Chapel Hill

Winston-Salem

Akron

Toledo

Oklahoma City

Pittsburgh

Sewickley

Fort Worth

Houston

Temple

Morgantown

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00775398 - Observational Study Assessing the Impact of Exposure to THROMBIN-JMI® on Coagulation Parameters. | Biotech Hunter | Biotech Hunter